Scientist reviewing translational evidence on a large analytical display.

Case study

Translational readiness gate review

A founder-led team needed to make a near-term go-or-refine call, but mechanism, endpoint, and market assumptions were scattered across decks and meeting notes.

Asset Development | Founder-led pain program team preparing for a go or refine decision

Client

Anonymized client

Founder-led pain program team preparing for a go or refine decision

A founder-led team needed to make a near-term go-or-refine call, but mechanism, endpoint, and market assumptions were scattered across decks and meeting notes.

Engagement context

Service trackAsset Development

ContextBiotech

FormatAnonymized case study

Challenge

The program had promising signal, but internal teams were using different definitions of readiness and different interpretations of what the data actually supported.

What NociWise did

  1. Reframed the core decision question and identified the evidence the team was implicitly relying on.
  2. Mapped key assumptions into a translational risk matrix with explicit confidence language.
  3. Packaged the findings into a leadership brief that separated immediate action items from unresolved watchouts.

Diagram

Engagement flow

  1. 01 Scope
  2. 02 Audit
  3. 03 Map
  4. 04 Package

Outcome

Stakeholders aligned on a narrower advance plan.

Evidence gaps became easier to discuss explicitly.

Follow-up questions were structured around concrete decision needs instead of the entire program narrative.

Proof points

One sprint moved the team from scattered evidence to a single recommendation path.

Three scenarios were ranked for leadership review with explicit tradeoffs.

One decision pack aligned translational and commercial stakeholders.